GlassScriptPhysician profile
Peter B Bressler
NPI 1972583656
$4,451.67
in general payments reported to CMS, 2019-2025
6 companies · $64.50 in 2025
The $64.50 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.84 · 2020: $4,317 · 2025: $64.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $64.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $64.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $3,000.00 | 2020 | |
| Astrazeneca Uk Limited | $1,317.33 | 2020 | |
| Glaxosmithkline, LLC. | $64.50 | 2025 | |
| Genentech USA, INC. | $36.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.19 | 2019 | |
| Tandem Diabetes Care, INC. | $13.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bressler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.